# Peripheral Intravenous Catheter Market > Peripheral Intravenous Catheter Market Research Report By Product Type (Standard Peripheral Intravenous Catheters, Safety Peripheral Intravenous Catheters, Implantable Peripheral Intravenous Catheters), By Material (Polyurethane, Teflon, Polyethylene), By Application (Intravenous Therapy, Blood Transfusion, Drug Administration), By Needle Gauge (16G, 18G, 20G), By End User (Hospitals, Clinics, Ambulatory Surgical Centers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.59% - **2024:** $ 9.62 Billion - **2025:** $ 10.16 Billion - **2035:** $ 17.5 Billion - **Key Players:** Becton Dickinson and Company (US), Smiths Medical (US), Terumo Corporation (JP), Medtronic plc (IE), Vygon S.A. (FR), Nipro Corporation (JP), Fresenius Kabi AG (DE), AngioDynamics, Inc. (US), Cardinal Health, Inc. (US) **Report ID:** MRFR/HC/28437-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/peripheral-intravenous-catheter-market-30180 --- ## Market Summary ## **Peripheral Intravenous Catheter Market Overview** As per MRFR analysis, the Peripheral Intravenous Catheter Market Size was estimated at 9.14 (USD Billion) in 2023. The Peripheral Intravenous Catheter Market Industry is expected to grow from 9.62 (USD Billion) in 2024 to 14.86 (USD Billion) by 2032. The Peripheral Intravenous Catheter Market CAGR (growth rate) is expected to be around 5.59% during the forecast period (2024 - 2032). ### **Key Peripheral Intravenous Catheter Market Trends Highlighted** Key market drivers for peripheral intravenous catheters include the increasing prevalence of chronic diseases, the growing adoption of minimally invasive surgeries, and technological advancements in catheter designs. Opportunities for market expansion lie in developing advanced catheters with enhanced safety features, antimicrobial coatings, and extended dwell times, as well as catering to the growing demand in emerging economies. Recent trends in the market have witnessed a shift towards safety-engineered catheters, needleless connectors, and smart infusion systems. The market is also driven by the need for effective and convenient fluid delivery systems, leading to the adoption of peripherally inserted central catheters (PICCs) and midline catheters. These trends suggest a growing demand for specialized and innovative peripheral intravenous catheters that meet the evolving needs of healthcare professionals and patients. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Intravenous Catheter Market Drivers** ### Increasing Prevalence of Chronic Diseases and Invasive Medical Procedures The rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, has led to an increased demand for peripheral intravenous catheters. These diseases often require long-term treatment and frequent administration of medications and fluids, which necessitates the use of reliable and efficient intravenous access devices. Additionally, the growing number of invasive medical procedures, including surgeries, biopsies, and diagnostic tests, has further contributed to the demand for peripheral intravenous catheters as they provide a safe and convenient means of administering fluids, medications, and other therapeutic agents. ### Technological Advancements and Product Innovations The Global Peripheral Intravenous Catheter Market Industry has witnessed significant technological advancements in recent years. Manufacturers are continuously investing in research and development to enhance the performance and safety of peripheral intravenous catheters. These advancements include the development of catheters with smaller diameters, improved materials, and enhanced safety features. For instance, the introduction of catheters with antimicrobial coatings has reduced the risk of infections and improved patient outcomes.Furthermore, the development of needle-free and self-inserting catheters has enhanced patient comfort and ease of use. ### Growing Focus on Patient Safety and Home Healthcare The increasing emphasis on patient safety and the shift towards home healthcare has also driven the growth of the Global Peripheral Intravenous Catheter Market Industry. Peripheral intravenous catheters offer a safe and convenient method of administering medications and fluids in both hospital and home settings. The growing preference for home healthcare, particularly for chronic disease management and post-operative care, has led to an increased demand for peripheral intravenous catheters that are easy to use, reliable, and minimize the risk of complications. ## **Peripheral Intravenous Catheter Market Segment Insights** ### **Peripheral Intravenous Catheter Market Product Type Insights** The Global Peripheral Intravenous Catheter Market segmentation by product type includes standard peripheral intravenous catheters, safety peripheral intravenous catheters, and implantable peripheral intravenous catheters. Standard peripheral intravenous catheters are the most common type, used for short-term intravenous therapy. Safety peripheral intravenous catheters have a safety mechanism to reduce the risk of needlestick injuries. The growth of the market can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in catheter design.Standard peripheral intravenous catheters dominate the market, accounting for the largest revenue share due to their widespread use in hospitals, clinics, and ambulatory surgical centers. Safety peripheral intravenous catheters are gaining popularity owing to their ability to prevent needlestick injuries, which is a major concern among healthcare professionals. Implantable peripheral intravenous catheters are expected to experience steady growth due to their advantages in long-term intravenous therapy. The Global Peripheral Intravenous Catheter Market is highly competitive, with numerous global and regional players.Key industry participants are focused on developing innovative products and expanding their geographic reach to cater to the growing demand for peripheral intravenous catheters. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Peripheral Intravenous Catheter Market Material Insights** The Material segment of the Global Peripheral Intravenous Catheter Market is segmented into Polyurethane, Teflon, and Polyethylene. Polyurethane dominates the market, capturing over 55% of the revenue in 2023. Its high strength, flexibility, and biocompatibility make it suitable for various applications. Teflon is expected to grow at a CAGR of 4.2% during 2024-2032 due to its inert properties and resistance to chemical reactions. Polyethylene, with a market share of around 20%, offers cost-effectiveness and is commonly used in short-term IV applications. ### **Peripheral Intravenous Catheter Market Application Insights** The Global Peripheral Intravenous Catheter Market is segmented based on application into intravenous therapy, blood transfusion, and drug administration. Among these, intravenous therapy held the largest market share in 2023, accounting for over 60% of the global market revenue. This is primarily attributed to the increasing prevalence of chronic diseases, such as cancer and diabetes, which require long-term intravenous therapy. The blood transfusion segment is also expected to witness significant growth over the forecast period, owing to the rising demand for blood transfusions in emergency situations and surgeries.The drug administration segment is anticipated to grow at a steady pace, driven by the increasing adoption of peripheral intravenous catheters for the administration of various drugs, including antibiotics, pain relievers, and chemotherapy drugs. ### **Peripheral Intravenous Catheter Market Needle Gauge Insights** The Needle Gauge segment is a crucial aspect of the Global Peripheral Intravenous Catheter Market, influencing market growth and segmentation. In 2024, the 16G segment held a significant market share, accounting for approximately 32% of the overall market revenue. This dominance is attributed to its versatility and widespread use in various clinical settings, including emergency and critical care units. The 18G segment follows closely, capturing around 28% of the market revenue in 2024. Its popularity stems from its suitability for administering fluids, medications, and blood transfusions. Meanwhile, the 20G segment is projected to exhibit steady growth, reaching a market share of approximately 22% by 2032. This segment caters to specific applications such as pediatric and geriatric care, where smaller gauge catheters are preferred for patient comfort and reduced risk of complications. The market data suggests that the Needle Gauge segment will continue to drive industry growth, with increasing demand for minimally invasive and effective [intravenous therapy](../../../reports/intravenous-therapy-vein-acces-market-32528) solutions. ### **Peripheral Intravenous Catheter Market End User Insights** The end-user segment of the Global Peripheral Intravenous Catheter Market is categorized into hospitals, clinics, and ambulatory surgical centers. Hospitals are expected to hold the largest market share due to the high volume of patients requiring intravenous therapy and the presence of advanced medical infrastructure. In 2023, the hospital segment is estimated to account for around 60% of the Global Peripheral Intravenous Catheter Market revenue. Clinics are projected to witness significant growth due to the increasing number of outpatient procedures and the convenience they offer to patients.Ambulatory surgical centers are anticipated to contribute a notable share of the market, driven by the growing demand for same-day surgeries. ### **Peripheral Intravenous Catheter Market Regional Insights** The regional segmentation of the Global Peripheral Intravenous Catheter Market offers valuable insights into the market's growth dynamics and competitive landscape. 'North America' is projected to account for a significant share of the Global Peripheral Intravenous Catheter Market revenue, driven by the presence of major market players, advanced healthcare infrastructure, and a high prevalence of chronic diseases. 'Europe' follows closely behind, with a robust healthcare system and a growing elderly population. 'APAC' is expected to witness substantial growth in the coming years, fueled by rising healthcare expenditure and increasing awareness about modern medical technologies.South America' and 'MEA' are also expected to contribute to the overall market growth, albeit at a slower pace. The Global Peripheral Intravenous Catheter Market is highly competitive, with key players focusing on product innovation, strategic partnerships, and geographical expansion to gain market share. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Intravenous Catheter Market Key Players And Competitive Insights** Major players in the Peripheral Intravenous Catheter Market industry are focusing on product development and innovation to gain a competitive edge in the market. Leading Peripheral Intravenous Catheter Market players are investing heavily in research and development to introduce advanced products with improved features and functionalities. The Peripheral Intravenous Catheter Market is characterized by the presence of intense competition among the top players. These players are continuously striving to gain market share by adopting various strategies such as product innovation, partnerships, and acquisitions. The Peripheral Intravenous Catheter Market Competitive Landscape is expected to remain highly competitive in the coming years. Key players are likely to focus on expanding their product portfolios, increasing their geographic presence, and enhancing their distribution networks to cater to the growing demand for peripheral intravenous catheters.BD is a leading global medical technology company that provides a wide range of products and services to the healthcare industry. The company's Peripheral Intravenous Catheter portfolio includes a variety of products designed to meet the needs of different patients and clinical settings. BD's Peripheral Intravenous Catheters are known for their high quality, reliability, and ease of use. The company has a strong distribution network and a global presence, which allows it to reach a wide range of customers. BD is committed to providing innovative and cost-effective solutions to meet the evolving needs of the healthcare industry.3M is a leading provider of healthcare products and services. The company's Peripheral Intravenous Catheter portfolio includes a wide range of products designed for various applications. 3M's Peripheral Intravenous Catheters are known for their safety, effectiveness, and reliability. The company has a strong research and development program, which allows it to develop and introduce new products to meet the evolving needs of the healthcare industry. 3M has a global presence and a strong distribution network, which allows it to reach a wide range of customers. The company is committed to providing innovative and cost-effective solutions to improve patient outcomes and reduce healthcare costs. ### **Key Companies in the Peripheral Intravenous Catheter Market Include** - Vygon - Merit Medical Systems, Inc. - Becton, Dickinson and Company - Convatec Group plc - **[Cardinal Health](https://shop.cardinalhealth.ca/chc/insyte-peripheral-venous-catheter)** - Terumo Corporation - Argon Medical Devices, Inc. - Smiths Medical - Baxter International Inc. - Smith Nephew - Braun Melsungen AG - BD (Becton, Dickinson and Company) - Asahi Intecc Co., Ltd. - Medtronic plc - Teleflex Incorporated ## Peripheral Intravenous Catheter Market Industry Developments - **Q2 2024: B. Braun Launches Introcan Safety® 2 IV Catheter in the U.S.** B. Braun Medical Inc. announced the U.S. launch of the Introcan Safety® 2 IV Catheter, designed to reduce needlestick injuries and improve patient safety, expanding its peripheral intravenous catheter portfolio. - **Q2 2024: Smiths Medical Announces FDA Clearance for Jelco Hypodermic Needle-Pro Edge Safety Device** Smiths Medical received FDA clearance for its Jelco Hypodermic Needle-Pro Edge Safety Device, a new safety-engineered peripheral IV catheter designed to minimize needlestick injuries among healthcare workers. - **Q1 2024: Teleflex Receives CE Mark for Arrow® VPS Rhythm® DLX Device** Teleflex Incorporated announced it has received CE Mark approval for its Arrow® VPS Rhythm® DLX Device, which assists in the placement of peripheral intravenous catheters, expanding its European market presence. - **Q2 2024: Vygon Group Acquires Medcaptain Peripheral IV Catheter Business** Vygon Group completed the acquisition of Medcaptain's peripheral IV catheter business, strengthening its vascular access product portfolio and expanding its global reach in the intravenous therapy market. - **Q3 2024: Nipro Medical Corporation Opens New Manufacturing Facility in Georgia** Nipro Medical Corporation inaugurated a new manufacturing facility in Georgia, USA, dedicated to the production of peripheral intravenous catheters to meet growing demand in North America. - **Q1 2024: Becton Dickinson appoints new president for Medication Delivery Solutions** Becton Dickinson (BD) announced the appointment of a new president for its Medication Delivery Solutions segment, which includes the company's peripheral intravenous catheter business. - **Q2 2024: Vascular Pathways Announces Series B Funding to Advance PIVC Technology** Vascular Pathways closed a Series B funding round to accelerate the development and commercialization of its next-generation peripheral intravenous catheter technology. - **Q2 2024: ICU Medical Launches NutriCath™ Peripheral IV Catheter for Neonatal Care** ICU Medical introduced the NutriCath™ Peripheral IV Catheter, specifically designed for neonatal and pediatric patients, expanding its product offerings in the pediatric vascular access market. - **Q3 2024: Smiths Medical Partners with Medline for U.S. Distribution of Peripheral IV Catheters** Smiths Medical entered into a partnership with Medline Industries for the exclusive U.S. distribution of its peripheral intravenous catheter products, aiming to enhance market penetration. - **Q1 2025: B. Braun Receives FDA Clearance for Next-Generation Peripheral IV Catheter** B. Braun Medical Inc. received FDA clearance for its next-generation peripheral IV catheter, featuring advanced safety and infection prevention technologies. - **Q2 2025: Teleflex Expands Manufacturing Capacity for Peripheral IV Catheters in Malaysia** Teleflex announced the expansion of its manufacturing facility in Malaysia to increase production capacity for peripheral intravenous catheters, supporting global demand. - **Q2 2025: Smiths Medical appoints new CEO to drive growth in vascular access business** Smiths Medical named a new CEO, with a strategic focus on expanding its vascular access and peripheral intravenous catheter business. ## **Peripheral Intravenous Catheter Market Segmentation Insights** ### **Peripheral Intravenous Catheter Market Product Type Outlook** - Standard Peripheral Intravenous Catheters - Safety Peripheral Intravenous Catheters - Implantable Peripheral Intravenous Catheters ### **Peripheral Intravenous Catheter Market Material Outlook** - Polyurethane - Teflon - Polyethylene ### **Peripheral Intravenous Catheter Market Application Outlook** - Intravenous Therapy - Blood Transfusion - Drug Administration ### **Peripheral Intravenous Catheter Market Needle Gauge Outlook** - 16G - 18G - 20G ### **Peripheral Intravenous Catheter Market End User Outlook** - Hospitals - Clinics - Ambulatory Surgical Centers ### **Peripheral Intravenous Catheter Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Rising Incidence of Chronic Diseases The Peripheral Intravenous Catheter Market is experiencing growth due to the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. These conditions often require long-term intravenous therapy, thereby driving demand for peripheral intravenous catheters. According to recent statistics, chronic diseases account for a significant portion of healthcare expenditures, necessitating efficient and reliable intravenous access. As healthcare systems adapt to manage these conditions, the need for advanced catheter technologies becomes paramount. This trend suggests that the Peripheral Intravenous Catheter Market will continue to expand as healthcare providers seek to improve patient outcomes through effective treatment options. ### Expansion of Healthcare Infrastructure The expansion of healthcare infrastructure is a crucial driver for the Peripheral Intravenous Catheter Market. As countries invest in improving their healthcare systems, the availability of advanced medical technologies, including peripheral intravenous catheters, is increasing. This expansion is particularly evident in emerging markets, where healthcare facilities are being upgraded to meet rising patient demands. Enhanced infrastructure facilitates better access to intravenous therapies, thereby driving the need for high-quality catheters. As healthcare systems evolve, the Peripheral Intravenous Catheter Market is poised for growth, reflecting the broader trends in healthcare development. ### Technological Innovations in Catheter Design Innovations in catheter design are propelling the Peripheral Intravenous Catheter Market forward. Manufacturers are increasingly focusing on developing catheters that enhance patient comfort and reduce complications. For instance, advancements in materials and coatings have led to catheters that minimize the risk of thrombosis and infection. The introduction of smart catheters equipped with sensors for real-time monitoring is also gaining traction. These technological advancements not only improve the efficacy of intravenous therapy but also align with the growing emphasis on patient safety and satisfaction. As a result, the Peripheral Intravenous Catheter Market is likely to witness a surge in demand for these innovative products. ### Increasing Demand for Home Healthcare Services The shift towards home healthcare services is influencing the Peripheral Intravenous Catheter Market significantly. As patients increasingly prefer receiving care in the comfort of their homes, the need for portable and easy-to-use intravenous solutions has risen. This trend is particularly evident among elderly patients and those with chronic conditions requiring ongoing treatment. The convenience of home healthcare is driving healthcare providers to adopt peripheral intravenous catheters that facilitate at-home administration of therapies. Consequently, this shift is expected to bolster the Peripheral Intravenous Catheter Market as more patients seek effective home-based treatment options. ### Growing Awareness of Infection Control Practices The Peripheral Intravenous Catheter Market is benefiting from heightened awareness regarding infection control practices. Healthcare facilities are increasingly implementing stringent protocols to minimize the risk of catheter-related infections. This awareness has led to the adoption of advanced catheter technologies designed to reduce infection rates, such as antimicrobial-coated catheters. The emphasis on infection prevention is not only improving patient safety but also reducing healthcare costs associated with treating complications. As healthcare providers prioritize infection control, the Peripheral Intravenous Catheter Market is likely to see a rise in demand for products that align with these practices. ## Future Outlook The Peripheral Intravenous Catheter Market is projected to grow at a 5.59% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare demands, and rising chronic diseases. **New opportunities:** - Development of smart IV catheters with integrated monitoring systems. Expansion into emerging markets with tailored product offerings. Partnerships with telehealth platforms for remote patient management solutions. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Standard Peripheral Intravenous Catheters (Largest) vs. Safety Peripheral Intravenous Catheters (Fastest-Growing) In the Peripheral Intravenous Catheter Market, Standard Peripheral Intravenous Catheters hold the largest share, driven by their widespread adoption in hospitals and clinics for routine intravenous therapies. In contrast, Safety Peripheral Intravenous Catheters, designed to enhance safety and reduce the risk of needlestick injuries, are gaining traction and are the fastest-growing segment, reflecting an increasing emphasis on patient and healthcare worker safety. Standard Peripheral Intravenous Catheters (Dominant) vs. Safety Peripheral Intravenous Catheters (Emerging) Standard Peripheral Intravenous Catheters dominate the market due to their established reliability and the trust healthcare providers have in them for various medical procedures. They are typically more cost-effective, making them the go-to choice for general application. On the other hand, Safety Peripheral Intravenous Catheters represent an emerging trend that focuses on minimizing the risks associated with traditional catheters. They incorporate safety features that significantly lower the injury rates among healthcare professionals, thus appealing to facilities aiming to enhance workplace safety and comply with strict regulations. ### By Material: Polyurethane (Largest) vs. Teflon (Fastest-Growing) In the Peripheral Intravenous Catheter Market, the material segment showcases a competitive landscape dominated by polyurethane, valued for its flexibility and durability, thus securing the largest market share. Polyethylene and Teflon, while prominent, are gaining traction due to niche applications and specific patient needs. Both materials cater to the increasing demand for specific medical procedures and conditions, contributing to a diversified offering in the market. Polyurethane (Dominant) vs. Teflon (Emerging) Polyurethane remains the dominant material in the Peripheral Intravenous Catheter Market, primarily due to its superior biocompatibility and resistance to kinking, which enhances patient comfort during prolonged use. In contrast, Teflon is emerging as a significant player, known for its smooth surface that reduces friction and enhances ease of insertion. As healthcare providers focus on minimizing complications, such as phlebitis and infiltration, Teflon's unique properties are expected to drive its growth in the coming years. The market's evolution is characterized by the continuous advancement of materials, leading to increased adoption rates of both segments. ### By Application: Intravenous Therapy (Largest) vs. Blood Transfusion (Fastest-Growing) The application segment of the Peripheral Intravenous Catheter Market is predominantly driven by Intravenous Therapy, which holds a significant share of the overall market. This method is widely utilized in clinical settings due to its efficacy in delivering fluids, medications, and nutrients directly to the bloodstream, enhancing patient recovery rates. In contrast, Blood Transfusion is emerging as the fastest-growing segment, fueled by an increasing number of surgical procedures, trauma cases, and a rise in chronic illnesses requiring blood products. This shift indicates a diversifying market landscape focused on a variety of patient needs. Application: Intravenous Therapy (Dominant) vs. Blood Transfusion (Emerging) Intravenous Therapy is the dominant application within the Peripheral Intravenous Catheter Market, characterized by its essential role in hospital care and outpatient treatment. This method ensures the swift administration of medication and fluids, making it indispensable in emergencies and routine treatments alike. Meanwhile, Blood Transfusion is emerging as a vital application, gradually gaining traction due to advancements in transfusion techniques and the increasing prevalence of conditions such as anemia and surgical requirements. The growth drivers for Blood Transfusion include improved patient management strategies and enhanced safety measures in transfusion practices, placing it as a key area of focus for manufacturers in this sector. ### By Needle Gauge: 18G (Largest) vs. 20G (Fastest-Growing) In the Peripheral Intravenous Catheter Market, the needle gauge segment showcases a diverse distribution of market shares among the various gauges. The 18G needle gauge holds the largest portion of the market due to its versatility and wide usage in clinical settings. In contrast, the 20G segment is emerging as a significant player, driven by its compatibility with various patient demographics as well as enhanced ease of use and reduced trauma for patients. Growth trends in the needle gauge segment are significantly influenced by increasing rates of hospital admissions and procedures necessitating peripheral intravenous access. Factors such as advancements in catheter technology, rising awareness about patient comfort, and government regulations promoting safer medical practices contribute to the positive growth trajectory of the 20G segment. As healthcare facilities focus on establishing patient-centered approaches, the demand for 20G catheters is expected to accelerate sharply in the coming years. 18G (Dominant) vs. 16G (Emerging) Within the needle gauge category, the 18G gauge stands out as the dominant force, preferred for its balance between fluid delivery capacity and patient comfort. This gauge is primarily utilized in a variety of medical procedures, facilitating efficient blood transfusions and infusions due to its larger lumen. Conversely, the 16G gauge, while less commonly used, is gaining recognition as an emerging choice for specific applications that require rapid fluid administration. Its higher caliber allows a considerable fluid flow, making it advantageous in emergency situations. The market positioning of these gauges reflects their utility in distinct medical contexts, aligning with evolving healthcare demands and innovations that prioritize both efficacy and patient safety. ### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing) In the Peripheral Intravenous Catheter Market, hospitals stand out as the largest end user segment, accounting for a significant portion of market activity. Their extensive infrastructure and critical care requirements drive the demand for peripheral IV catheters, making them central to the overall market dynamics. Clinics, while smaller in market share compared to hospitals, are witnessing a rapid rise in utilization as they increasingly adopt advanced catheter technologies for outpatient care and minor surgical procedures. Hospitals (Dominant) vs. Clinics (Emerging) Hospitals play a dominant role in the Peripheral Intravenous Catheter Market due to their higher patient volumes and need for sophisticated healthcare solutions. These facilities not only utilize these catheters for a wide range of applications, including surgeries and emergency care, but they also invest in training and technology to ensure optimal patient outcomes. On the other hand, clinics are emerging as significant players, fueled by the growing preference for minimally invasive procedures and outpatient services. Their adoption of peripheral IV catheters is bolstered by technological advancements that enable easier handling and greater patient comfort, reflecting a shift towards decentralized healthcare delivery. ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America is the largest market for peripheral intravenous catheters, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and a rising number of surgical procedures. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The United States is the primary contributor, with key players such as Becton Dickinson and Company, Smiths Medical, and Cardinal Health leading the competitive landscape. The presence of established healthcare facilities and a focus on innovative catheter technologies enhance market dynamics. Canada also plays a significant role, contributing to the overall growth with its robust healthcare system and increasing demand for quality medical devices. ### Europe : Emerging Market with Growth Potential Europe is witnessing significant growth in the peripheral intravenous catheter market, accounting for approximately 30% of the global share. Factors such as an aging population, increasing healthcare expenditure, and advancements in medical technology are driving demand. Regulatory frameworks, including the Medical Device Regulation (MDR), ensure high standards for product safety and efficacy, further boosting market confidence. Leading countries in this region include Germany, France, and the UK, where major players like Fresenius Kabi AG and Vygon S.A. are prominent. The competitive landscape is characterized by a mix of established companies and innovative startups, focusing on developing advanced catheter technologies. The region's emphasis on improving patient care and reducing hospital-acquired infections is expected to propel market growth further. ### Asia-Pacific : Rapidly Growing Healthcare Sector Asia-Pacific is emerging as a significant player in the peripheral intravenous catheter market, holding around 20% of the global market share. The region's growth is fueled by increasing healthcare investments, a rising population, and a growing prevalence of chronic diseases. Countries like China and India are witnessing rapid advancements in healthcare infrastructure, which are essential for market expansion. Regulatory bodies are also becoming more stringent, ensuring the quality of medical devices. China is the largest market in the region, followed by India and Japan. The competitive landscape features both local and international players, including Terumo Corporation and Nipro Corporation. The focus on affordable healthcare solutions and the increasing number of hospitals and clinics are driving the demand for peripheral IV catheters, making this region a key area for future growth. ### Middle East and Africa : Untapped Market with Opportunities The Middle East and Africa region is gradually emerging in the peripheral intravenous catheter market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of advanced medical technologies, and a growing patient population. Governments are focusing on improving healthcare infrastructure, which is crucial for market development. Regulatory bodies are also beginning to implement stricter guidelines to ensure product safety and efficacy. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities and an increasing demand for quality medical devices. The competitive landscape is characterized by a mix of local and international players, with opportunities for growth in both urban and rural healthcare settings. The region's focus on enhancing healthcare access and quality is expected to drive the demand for peripheral IV catheters in the coming years. ## Competitive Benchmarking The Peripheral Intravenous Catheter Market is currently characterized by a dynamic competitive landscape, driven by increasing healthcare demands and technological advancements. Major players such as Becton Dickinson and Company (US), Terumo Corporation (JP), and Medtronic plc (IE) are strategically positioned to leverage innovation and expand their market presence. Becton Dickinson and Company (US) focuses on enhancing product safety and efficacy through continuous research and development, while Terumo Corporation (JP) emphasizes regional expansion and partnerships to strengthen its distribution networks. Medtronic plc (IE) is actively pursuing digital transformation initiatives, integrating advanced technologies into its product offerings, which collectively shapes a competitive environment that prioritizes innovation and responsiveness to market needs.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships, thereby enhancing their competitive edge. In August Becton Dickinson and Company (US) announced the launch of a new line of safety-engineered IV catheters designed to minimize the risk of needlestick injuries. This strategic move not only addresses growing safety concerns among healthcare professionals but also positions the company as a leader in innovation within the market. The introduction of these products is likely to enhance Becton Dickinson's market share and reinforce its commitment to patient safety. In September Terumo Corporation (JP) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its IV catheter systems. This collaboration signifies a shift towards digital health solutions, allowing for real-time patient data collection and improved clinical outcomes. Such strategic alliances may enhance Terumo's competitive positioning by aligning its products with the evolving needs of healthcare providers. In October Medtronic plc (IE) unveiled a new AI-driven analytics platform aimed at optimizing [IV catheter](https://www.marketresearchfuture.com/reports/intravascular-catheter-market-7966) placement and management. This innovative approach not only streamlines clinical workflows but also enhances patient care by reducing complications associated with catheter use. Medtronic's focus on integrating artificial intelligence into its offerings reflects a broader trend within the industry towards leveraging technology for improved healthcare delivery. As of October the competitive trends within the Peripheral Intravenous Catheter Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming pivotal in shaping the landscape, as companies seek to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability, underscoring the importance of adaptability in a rapidly changing market. ## Recent News & Developments - **Q2 2024: B. Braun Launches Introcan Safety® 2 IV Catheter in the U.S.** B. Braun Medical Inc. announced the U.S. launch of the Introcan Safety® 2 IV Catheter, designed to reduce needlestick injuries and improve patient safety, expanding its peripheral intravenous catheter portfolio. - **Q2 2024: Smiths Medical Announces FDA Clearance for Jelco [Hypodermic Needle](https://www.marketresearchfuture.com/reports/hypodermic-needle-market-41146)-Pro Edge Safety Device** Smiths Medical received FDA clearance for its Jelco Hypodermic Needle-Pro Edge Safety Device, a new safety-engineered peripheral IV catheter designed to minimize needlestick injuries among healthcare workers. - **Q1 2024: Teleflex Receives CE Mark for Arrow® VPS Rhythm® DLX Device** Teleflex Incorporated announced it has received CE Mark approval for its Arrow® VPS Rhythm® DLX Device, which assists in the placement of peripheral intravenous catheters, expanding its European market presence. - **Q2 2024: Vygon Group Acquires Medcaptain Peripheral IV Catheter Business** Vygon Group completed the acquisition of Medcaptain's peripheral IV catheter business, strengthening its vascular access product portfolio and expanding its global reach in the intravenous therapy market. - **Q3 2024: Nipro Medical Corporation Opens New Manufacturing Facility in Georgia** Nipro Medical Corporation inaugurated a new manufacturing facility in Georgia, USA, dedicated to the production of peripheral intravenous catheters to meet growing demand in North America. - **Q1 2024: Becton Dickinson appoints new president for Medication Delivery Solutions** Becton Dickinson (BD) announced the appointment of a new president for its Medication Delivery Solutions segment, which includes the company's peripheral intravenous catheter business. - **Q2 2024: Vascular Pathways Announces Series B Funding to Advance PIVC Technology** Vascular Pathways closed a Series B funding round to accelerate the development and commercialization of its next-generation peripheral intravenous catheter technology. - **Q2 2024: ICU Medical Launches NutriCath™ Peripheral IV Catheter for Neonatal Care** ICU Medical introduced the NutriCath™ Peripheral IV Catheter, specifically designed for neonatal and pediatric patients, expanding its product offerings in the pediatric vascular access market. - **Q3 2024: Smiths Medical Partners with Medline for U.S. Distribution of Peripheral IV Catheters** Smiths Medical entered into a partnership with Medline Industries for the exclusive U.S. distribution of its peripheral intravenous catheter products, aiming to enhance market penetration. - **Q1 2025: B. Braun Receives FDA Clearance for Next-Generation Peripheral IV Catheter** B. Braun Medical Inc. received FDA clearance for its next-generation peripheral IV catheter, featuring advanced safety and infection prevention technologies. - **Q2 2025: Teleflex Expands Manufacturing Capacity for Peripheral IV Catheters in Malaysia** Teleflex announced the expansion of its manufacturing facility in Malaysia to increase production capacity for peripheral intravenous catheters, supporting global demand. - **Q2 2025: Smiths Medical appoints new CEO to drive growth in vascular access business** Smiths Medical named a new CEO, with a strategic focus on expanding its vascular access and peripheral intravenous catheter business. ## Report Scope | MARKET SIZE 2024 | 9.62(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 10.16(USD Billion) | | MARKET SIZE 2035 | 17.5(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.59% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Becton Dickinson and Company (US), Smiths Medical (US), Terumo Corporation (JP), Medtronic plc (IE), Vygon S.A. (FR), Nipro Corporation (JP), Fresenius Kabi AG (DE), AngioDynamics, Inc. (US), Cardinal Health, Inc. (US) | | Segments Covered | Product Type, Material, Application, Needle Gauge, End User, Regional | | Key Market Opportunities | Integration of smart technology in Peripheral Intravenous Catheter Market enhances patient safety and monitoring capabilities. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Peripheral Intravenous Catheter market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Peripheral Intravenous Catheter Market by 2035?** A: The Peripheral Intravenous Catheter Market is projected to reach a valuation of 17.5 USD Billion by 2035. **Q: What was the market valuation of the Peripheral Intravenous Catheter Market in 2024?** A: In 2024, the market valuation of the Peripheral Intravenous Catheter Market was 9.62 USD Billion. **Q: What is the expected CAGR for the Peripheral Intravenous Catheter Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Peripheral Intravenous Catheter Market during the forecast period 2025 - 2035 is 5.59%. **Q: Which companies are considered key players in the Peripheral Intravenous Catheter Market?** A: Key players in the market include Becton Dickinson and Company, Smiths Medical, Terumo Corporation, and Medtronic plc. **Q: What are the projected revenues for Standard Peripheral Intravenous Catheters by 2035?** A: The projected revenues for Standard Peripheral Intravenous Catheters are expected to reach 6.88 USD Billion by 2035. **Q: How do Safety Peripheral Intravenous Catheters perform in terms of market valuation?** A: Safety Peripheral Intravenous Catheters are projected to achieve a market valuation of 5.75 USD Billion by 2035. **Q: What is the anticipated market size for Implantable Peripheral Intravenous Catheters by 2035?** A: The anticipated market size for Implantable Peripheral Intravenous Catheters is expected to be 4.87 USD Billion by 2035. **Q: Which material segment is expected to dominate the Peripheral Intravenous Catheter Market by 2035?** A: The Polyurethane material segment is projected to dominate the market, reaching 6.93 USD Billion by 2035. **Q: What is the expected market size for intravenous therapy applications by 2035?** A: The expected market size for intravenous therapy applications is projected to be 7.04 USD Billion by 2035. **Q: How does the end-user segment for hospitals compare to clinics in 2035?** A: By 2035, the market size for hospitals is expected to be 8.0 USD Billion, significantly higher than the 4.5 USD Billion projected for clinics. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-intravenous-catheter-market-30180*